Main Industry
Health Care
Main Product/Service
Collagen Solution
3D Collagen Printing Gel (3D ColLive Gel)
Non-recombinant Porous Collagen Matrix (nPCM)
Regenerative Medicine Dermis (RegDerm)
Collagen and Related Derivative Product Technical Services
3D Collagen Printing Gel (3D ColLive Gel)
Non-recombinant Porous Collagen Matrix (nPCM)
Regenerative Medicine Dermis (RegDerm)
Collagen and Related Derivative Product Technical Services
Founded Year
2022
Unified Business No.
90401152
Status
Active
Number of Employees
8
Total Paid-in
Capital
45,408,600 (NT$)
Location of Company
Taiwan
, Tainan City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
FMG Biomed has developed nPCM, a patented non-reconstituted porous collagen matrix that prevents scaffold collapse. Its flagship RegDerm™ dermal prosthesis accelerates fibroblast infiltration 4× faster than global benchmarks — targeting wound care, tissue engineering, and ischemic wounds through U.S. distribution partnerships and CDMO collaborations.
